Frederick John Livesey
Gründer bei Talisman Therapeutics Ltd.
Aktive Positionen von Frederick John Livesey
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Talisman Therapeutics Ltd.
 Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
| Gründer | - | - |
Karriereverlauf von Frederick John Livesey
Ehemalige bekannte Positionen von Frederick John Livesey
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Gen2 Neuroscience Ltd.
 Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Vorstandsvorsitzender | 07.01.2016 | - |
| Gründer | 07.01.2016 | - |
Statistik
International
| Vereinigtes Königreich | 3 |
Operativ
| Founder | 2 |
| Chief Executive Officer | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Gen2 Neuroscience Ltd.
Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Talisman Therapeutics Ltd.
Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Frederick John Livesey
- Erfahrung
